And yet, no one actually factually disputed my point. If you...

And yet, no one actually factually disputed my point.

If you think small small potatoes like us have any major effect on the share price, you’re dreaming.

But again, I’m not criticising as much as looking at the upcoming data with a little more realism. I personally think we will see more share price action with additional programs instead of sheep data because it will likely be more of a reiteration of past findings, which isn’t terribly new. The real rubber meets the road with OPMD when we have interim (if they release such) OPMD in-human efficacy data.